e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.60p
   
  • Change Today:
      0.43p
  • 52 Week High: 23.10p
  • 52 Week Low: 8.13p
  • Currency: UK Pounds
  • Shares Issued: 584.34m
  • Volume: 2,228,014
  • Market Cap: £56.10m

Deal with Barclays    Trade now with Barclays Stockbrokers

Regulatory News

Proposed Fundraise of £28.9m and Cancellation 10-Apr-2024 07:00 RNS
Total Voting Rights 31-Jan-2024 16:30 RNS
Exercise of Options and Issue of Equity 24-Jan-2024 10:04 RNS
Business Update 16-Jan-2024 07:00 RNS
Director Dealing and Issue of Equity 09-Jan-2024 16:04 RNS
Update on OTCQX Market Listing 27-Dec-2023 07:00 RNS
Strategic RWE collaboration with Arcturis 02-Nov-2023 07:00 RNS
Interim results for the six months to 31 July 2023 26-Oct-2023 07:38 RNS
Notice of Interim Results 19-Oct-2023 09:54 RNS
Senior Management Update 20-Sep-2023 07:00 RNS
Exercise of Options and Issue of Equity 07-Sep-2023 11:47 RNS
Total Voting Rights 31-Jul-2023 16:30 RNS
Result of Annual General Meeting 18-Jul-2023 16:20 RNS
Director Dealing and Issue of Equity 06-Jul-2023 17:27 RNS
Notice of AGM and Posting of Annual Report 11-May-2023 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 9.60p
Change Today 0.43p
% Change 4.63 %
52 Week High 23.10p
52 Week Low 8.13p
Volume 2,228,014
Shares Issued 584.34m
Market Cap £56.10m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.37% below the market average21.37% below the market average21.37% below the market average21.37% below the market average21.37% below the market average
50.94% above the sector average50.94% above the sector average50.94% above the sector average50.94% above the sector average50.94% above the sector average
Price Trend
65.69% below the market average65.69% below the market average65.69% below the market average65.69% below the market average65.69% below the market average
19.30% above the sector average19.30% above the sector average19.30% above the sector average19.30% above the sector average19.30% above the sector average
Income Not Available
Growth
15.26% below the market average15.26% below the market average15.26% below the market average15.26% below the market average15.26% below the market average
24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average

e-Therapeutics Dividends

No dividends found

Trades for 25-Apr-2024

Time Volume / Share Price
10:05 560,000 @ 9.00p
16:15 30,000 @ 9.67p
16:06 50,000 @ 9.40p
16:06 65,677 @ 9.35p
15:26 3,761 @ 9.20p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page